Is loss of ARID1A-associated protein expression a frequent event in clear cell and endometrioid ovarian cancers?
These data confirm that loss of the ARID1A-encoded protein BAF250a is a frequent event in the genesis of clear cell and endometrioid ovarian cancers. Loss of BAF250a was not associated with clinical or epidemiologic characteristics. One explanation for these findings is that inactivation of the chromatin remodeling pathway may be a requisite event in the development of these cancers.
Users of MHS visit GPs substantially more often than non-users, with the exception of those with no fixed address who seldom see a GP at all.